Journal of Clinical Pharmacy & Therapeutics

Pharm-ing cyberspace: the Internet as a tool for evidence based pharmacotherapy
pp. 159-163(5)
Author: Booth, A.

Drug misuse and harm reduction: pharmacy's magnificent contribution, but at what cost?
pp. 165-169(5)
Author: Peterson, G. M.

Attitudes of pharmacists and physicians to antibiotic policies in hospitals
pp. 181-189(9)
Authors: Adu, A.; Simpson, J. M.; Armour, C. L.

Clozapine-olanzapine: a potentially dangerous switch. A report of two cases
pp. 191-195(5)
Authors: delassus-Guenault, N.; Jegouzo, A.; Odou, P.; Seguret, T.; Zangerlin, H.; Vignole, E.; Robert, H.

The effect of doctor ethnicity and country of qualification on prescribing patterns: an ecological study
pp. 197-202(6)
Authors: Gill, P. S.; Dowell, A.; Harris, C. M.

The effect of doctor ethnicity and country of qualification on prescribing patterns: an ecological study
pp. 197-202(6)
Authors: Gill, P.S.; Dowell, A.; Harris, C.M.

Population analysis for the optimization of digoxin treatment in Japanese paediatric patients
pp. 203-208(6)
Authors: Suematsu, F.; Minemoto, M.; Yukawa, E.; Higuchi, S.

A survey of the treatment of female patients with osteoporosis using drug utilization consumption parameters
pp. 209-217(9)
Authors: Truter, I.; Serfontein, J.H.P.

Comparative bioavailability of three different preparations of rifampicin
pp. 219-225(7)
Authors: Pähkla, R.; Lambert, J.; Ansko, P.; Winstanley, P.; Davies, P.D.O.; Kiivet, R-A.

Stability of the X-ray contrast agent iodixanol=3,3′,5,5′-tetrakis(2,3-dihydroxypropylcarbamoyl)-2,2′,4,4′,6,6′-hexaiodo-N,N′-(2-hydroxypropane-1,3-diyl)-diacetanilide towards acid, base, oxygen, heat and light
pp. 227-235(9)
Authors: Priebe, H.; Aukrust, A.; Bjørsvik, H.; Tønseth, C.P.; Wiggen, U.N.